Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(6): 960-967
DOI: https://doi.org/10.20546/ijcmas.2019.806.116


Seroprevalence of Measles Antibodies among Young Adults in a Tertiary Care Hospital, India
L. Prashanthi, N. Sridevi*, Dara Saranya and P. Sashikala Reddy
Dept of Microbiology, Osmania Medical College, Hyderabad, India
*Corresponding author
Abstract:

Measles is a highly contagious vaccine-preventable disease caused by the Morbilivirus. Measles vaccine was introduced in India in 1985 as a part of Universal Immunization Programme (UIP) which was given at 9 completed months of age. As vaccine coverage has increased, there has been a marked reduction in measles incidence in the pediatric age group; but at the same time, the average age, at which measles infection occurs, has significantly increased. Many countries have reported diminishing of antibody titres against measles among young population as immunization coverage of adolescents and adults in not monitored. To determine seroprevalence of IgG antibodies titres against measles in young adults. It is a cross sectional study, conducted over 6 months (JUNE to NOVEMBER 2018) Sample size is 200. Study population belonged to 15-30 yrs of age. Samples – serum (Blood) Measles IgG ELISA Kit (EUROIMMUN). Out of the 200 samples collected, 65.6% had protective titres, 21.9% of the study group showed susceptibility i.e. they had unprotective levels of antibody titres and 12.5% were in the borderline titre group. Most of the individuals were vaccinated with a single dose of measles vaccine. Several reports have shown that the susceptibility to measles infection may be rising because of waning vaccine induced immunity over time after vaccination, in the absence of natural boosting by circulating measles viruses While most of the immunization drives in developing countries are aimed at children, it is important to recognize and identify pockets of susceptible populations that could jeopardize the prevention and control of these vaccine preventable diseases. Hence there is a need for serosurveillance and mop -up programs to cover these pockets of susceptible population so as to reach the WHO goal of Measles Eradication by 2020.


Keywords: Measles, Antibodies, Adults, IgG ELISA Kit
Download this article as Download

How to cite this article:

Prashanthi, L., N. Sridevi, Dara Saranya and Sashikala Reddy, P. 2019. Seroprevalence of Measles Antibodies among Young Adults in a Tertiary Care Hospital, India.Int.J.Curr.Microbiol.App.Sci. 8(6): 960-967. doi: https://doi.org/10.20546/ijcmas.2019.806.116